Abstract
The clinical efficacy of non-steroidal, anti-inflammatory drugs (NSAIDs) is undisputed, as is their propensity to induce gastrointestinal mucosal lesions. Although several new substances and formulations have been developed during the past decades in the search for drugs with a more favourable side effect profile, the difference between the individual drugs remains small and is overshadowed by the interindividual variation in sensitivity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
